Cargando…
Marked Reduction in the Striatal Dopamine Transporter Uptake During the Early Stage of Motor Symptoms in Patients with the MAPT N279K Mutation
We herein report two patients harboring the mutation N279K in microtubule-associated protein tau (MAPT), who showed parkinsonism with a disease duration within three years from the onset, evaluated by dopamine transporter (DAT) [(123)I]N-ω-fluoroprophyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane sing...
Autores principales: | Takeshige, Haruka, Nakayama, Sachiko, Nishioka, Kenya, Li, Yuanzhe, Motoi, Yumiko, Hattori, Nobutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232026/ https://www.ncbi.nlm.nih.gov/pubmed/29877269 http://dx.doi.org/10.2169/internalmedicine.0454-17 |
Ejemplares similares
-
Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features
por: Ikeda, Aya, et al.
Publicado: (2019) -
Molecular genetics of Parkinson’s disease: Contributions and global trends
por: Funayama, Manabu, et al.
Publicado: (2022) -
A complex form of hereditary spastic paraplegia harboring a novel variant, p.W1515*, in the SPG11 gene
por: Daida, Kensuke, et al.
Publicado: (2022) -
CSF1R Mutation p.G589R and the Distribution Pattern of Brain Calcification
por: Daida, Kensuke, et al.
Publicado: (2017) -
Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
por: Nishioka, Kenya, et al.
Publicado: (2022)